Antidotes Global Market Report 2024

The global antidotes market has grown strongly in recent years. It will grow from $2.04 billion in 2023 to $2.23 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to poison control centers, regulatory approvals, industrial and occupational safety, education and training.

The global antidotes market is expected to see strong growth in the next few years. It will grow to $3.27 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to drug overdose crisis, emerging toxins, regulatory support, telemedicine and remote consultation. Major trends in the forecast period include combination antidotes, personalized poison management, digital poison control, pediatric antidotes.

The growing number of poison incidents is poised to drive the expansion of the antidotes market in the near future. Poison incidents encompass situations where individuals are exposed to, ingest, or come into contact with substances that are harmful or toxic to their health. In such cases, antidotes play a pivotal role as they can counteract the effects of these dangerous substances. Antidotes work by neutralizing, mitigating, or reversing the detrimental consequences of poisoning. For example, as of August 2022, a report from The Office for National Statistics, a UK-based government department, highlighted that in England and Wales, there were 4,859 fatalities related to drug poisoning in 2021. This corresponds to an annual mortality rate of 84.4 per million individuals, signifying a 6.2% increase from the rate of 79.5 per million recorded in 2020. Consequently, the upsurge in poison incidents is a driving force behind the growth of the antidotes market.

The burgeoning prevalence of various medical conditions is anticipated to propel the growth of the antidotes market. Medical conditions encompass diseases, illnesses, or injuries, such as opioid poisoning, cyanide poisoning, or benzodiazepine poisoning, that adversely affect the structure or function of an organism. These conditions can often be treated or prevented using antidotes. Antidotes are essential for addressing or preventing poisonings and mitigating the detrimental effects of toxins. They work by binding to the poisonous substances, rendering them harmless, or blocking their adverse impacts on the body. For instance, data from the Centers for Disease Control and Prevention, a US-based national public health agency, in August 2023, revealed that the United States witnessed approximately 45 deaths per day due to prescription opioid overdoses, totaling nearly 17,000 fatalities in 2021. Furthermore, over 9,000 individuals succumbed to heroin overdoses in the same year. Hence, the upswing in the prevalence of medical conditions is a significant driver of growth in the antidotes market.

The scarcity of skilled professionals is expected to present a hindrance and impede the market's growth in the foreseeable future. Workforce shortages signify an insufficiency of adequately trained workers to fill the available job vacancies within a specific labor market. The absence of proficient professionals capable of administering treatments with these antidotes is affecting the overall market demand. As an example, a report from the Association of American Medical Colleges, a US-based non-profit organization, in May 2023, projected that the United States is likely to experience a shortage of up to 124,000 physicians by 2034, as the demand surpasses the available supply. Consequently, the shortage of skilled professionals is hampering the growth of the antidotes market.

Prominent market players are dedicating their efforts to introduce innovative products like atropine sulfate injections to extend their market presence and provide enhanced treatment alternatives. Atropine sulfate injection is a type of antimuscarinic medication designed to inhibit the action of acetylcholine at muscarinic receptors within the parasympathetic nervous system. For instance, in August 2022, American Regent Inc., a US-based pharmaceutical company specializing in sterile injectables for healthcare providers, launched an atropine sulfate injection, USP. This traditional injectable medication is used as an antisialagogue, an antidote for organophosphorus poisoning or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest. Its primary purpose is to temporarily block severe or life-threatening muscarinic effects.

In July 2022, Soligenix Inc., a US-based biopharmaceutical company, established a partnership with SERB Pharmaceuticals to develop a novel ricin antigen for the treatment of ricin toxin poisoning. This collaboration aims to create a medical solution for ricin toxin poisoning. It combines Soligenix's antigen expertise with SERB Pharmaceuticals' proficiency in antibody research and manufacturing. SERB Pharmaceuticals, based in France, specializes in emergency care and is dedicated to developing and providing antidotes for critical conditions.

Major players in the antidotes market are Pfizer Inc., Johnson & Johnson, Merck & Co., Bayer AG, Novartis AG, Bristol Myers Squibb, Alexion Pharmaceuticals Inc., AstraZeneca PLC, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., CSL Behring, Daiichi Sanko Inc., Fresenius Kabi AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Ferring B.V., Lupin Limited, Zydus Lifesciences Ltd., Mallinckrodt Pharmaceuticals Ltd., Nichi-Iko Pharmaceutical Co. Ltd., Akorn Incorporated, Meridian Medical Technologies Inc., Alvogen Pharma India Pvt. Ltd., Wockhardt Limited, ADAPT Pharma Inc.

North America was the largest region in the antidotes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antidotes report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the antidotes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Antidotes come in several types, including chemical antidotes, physical antidotes, pharmacological antidotes, and others. Chemical antidotes are substances or compounds specifically formulated to counteract the toxic effects of particular chemical substances or poisons. They are employed in situations where exposure to a harmful substance has occurred, with the objective of neutralizing, mitigating, or reversing the toxic effects. These chemical antidotes can be administered through various forms, such as injectables, oral medications, capsules, tablets, and syrups. They find applications in diverse scenarios, including the treatment of animal bites and heavy metal poisoning, and are typically administered by healthcare providers in hospitals, homecare settings, specialty clinics, and other relevant healthcare facilities.

This report provides antidotes market statistics, including antidotes industry global market size, regional shares, competitors with an antidotes market share, detailed antidotes market segments, market trends and opportunities and any further data you may need to thrive in the antidotes industry. This antidotes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The antidotes market consists of sales of opioid antidotes, anticholinergic antidotes, benzodiazepine antidotes, anticoagulant antidotes, iron chelators, cyanide antidotes, heavy metal antidotes and digoxin antidotes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.